Akouos, a biotech startup that's trying to tackle a $750 billion global problem, just announced it's raised a new funding round

Shutterstock

• Boston-based biotech startup Akouos is the first of its kind to use gene therapy to tackle genetic-based hearing disorders. 
• The company announced $50 million in Series A funding on Tuesday.
• The funding will help Akouos advance its first program into human trials, support its pipeline for therapies, and build out both its team and its platform. 

---

Akouos is a new biotech startup that's trying to address a $750 billion problem: hearing loss. 

Manny Simons, co-founder and CEO of Akouos, spent his college and grad school years figuring out the biology of the ear and how to deliver drugs to the right parts of the ear. His interests drew him to his now co-founders at Massachusetts Eye and Ear about 15 years ago. 

See the rest of the story at Business Insider

NOW WATCH: Why penalty kicks are so unfair to goalies

See Also:

• Ovid Therapeutics shares fall 28% as investors question new drug data
• The former CEO of GE pinpoints the moment he realized healthcare was his problem
• DNA-testing companies like 23andMe sell your genetic data to drugmakers and other Silicon Valley startups

SEE ALSO: A medical diagnostics startup that wants to use CRISPR technology to detect diseases just raised $23 million in venture funding

from Business Insider https://ift.tt/2OeEC7E